Published in Medical Letter on the CDC and FDA, January 17th, 2000
Results of the study, published in the January 5, 2000, issue of the Journal of the American Medical Association (JAMA), also showed that liver toxicity was five times higher with taking one particular protease inhibitor, ritonavir, which accounted for half of all cases in the study.
"Based on anecdotal reports, there had been a feeling that all protease inhibitors were equally toxic to the liver and that is not what we found," says...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA